Goldman A
Br J Cancer. 1981 Dec;44(6):872-8. doi: 10.1038/bjc.1981.286.
Twentynine children with non-Hodgkin's lymphomas (NHL) were treated between 1974 and 1977 with a protocol based on those used for childhood ALL. 76% of patients had advanced disease by Ann Arbor criteria. All tumours had Rappaport's diffuse histology. 19 patients (65%) achieved complete remission, 14 (65%) remained alive and disease free beyond 42 months from diagnosis. 10 patients failed to enter complete remission, of whom all died. 7 patients relapsed; 5 died, 2 remain disease free and off treatment at 19 and 29 months. Comparison with a historic group of 20 consecutively treated children shows improved survival (P less than 0.01). 18 controls died. Histology was reviewed using the Kiel classification and staging according to Murphy's criteria. These are compared with the methods used initially. The improved outlook for children with NHL using intensive multiple drug regimes and cranial prophylaxis is confirmed. In staging childhood NHL, Murphy's criteria, which take into account the natural history of the disease, have greater prognosis value. Histology and pattern of outcome of the disease suggest basic differences between primary abdominal and primary mediastinal and nodal disease. This is now being confirmed with immunological typing and will be reflected in the development of future protocols.
1974年至1977年间,29名非霍奇金淋巴瘤(NHL)患儿接受了基于儿童急性淋巴细胞白血病(ALL)治疗方案的治疗。根据安阿伯标准,76%的患者患有晚期疾病。所有肿瘤均为拉帕波特弥漫性组织学类型。19名患者(65%)实现完全缓解,14名(65%)在诊断后42个月以上仍存活且无疾病。10名患者未能进入完全缓解,全部死亡。7名患者复发;5名死亡,2名在19个月和29个月时仍无疾病且停止治疗。与一组连续接受治疗的20名历史对照儿童相比,生存率有所提高(P<0.01)。18名对照死亡。使用基尔分类法对组织学进行了复查,并根据墨菲标准进行分期。将这些与最初使用的方法进行了比较。使用强化多药方案和颅脑预防措施对NHL患儿预后改善得到了证实。在儿童NHL分期中,考虑到疾病自然史的墨菲标准具有更大的预后价值。疾病的组织学和转归模式表明原发性腹部、原发性纵隔和淋巴结疾病之间存在基本差异。目前这一点正通过免疫分型得到证实,并将在未来治疗方案的制定中得到体现。